Actively Recruiting
Pilot Study of Intravenous Zanamivir to Treat Blood Vessel Leakage in Dengue Fever in Patients Aged 7 and Older
Led by George Washington University · Updated on 2026-07-29
74
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the safety and effectiveness of intravenous zanamivir treatment in patients with dengue fever who experience vascular permeability syndrome, a severe complication that is the main cause of death in this disease. The study is a pilot, randomized, double-blind, placebo-controlled trial involving male and non-pregnant female participants aged 7 years and older from Colombia, diagnosed with dengue fever according to WHO criteria and confirmed by a rapid dengue NS1 test. Participants will be randomly assigned to receive either intravenous zanamivir or a placebo. Those in the zanamivir group will receive doses based on their weight12 mgkg for those under 50 kg and 600 mg for those 50 kg or aboveadministered every twelve hours for five days, with adjustments for kidney function. Participants in the placebo group will receive an intravenous saline solution on the same schedule for five days. Throughout the five-day treatment period and at a follow-up visit on day 14, participants will undergo daily blood tests to monitor hematocrit levels, kidney function, and biological markers related to treatment effects. Clinical evaluations will assess signs of vascular permeability using ultrasound or radiographs as needed, along with monitoring for any adverse events. The primary outcome is the rate of treatment-related adverse events over 14 days, while secondary outcomes include biomarker levels and preliminary clinical efficacy assessments.
CONDITIONS
Brief Title
Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)
Research Team
A
Aileen Y Chang, MD
A
Alfonso Sucerquia, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here